Replies to post #370621 on Amarin Corp Plc (AMRN)

[Whalatane]

Well there are a lot of factors to consider now
Will Marjac ‘s case be remand back to consider new evidence ( Curfman / Bhatt ) and possible fraud ( the cropped K table )

Will MITIGATE on April 3 show 15% less hospitalization for Covid in the Vascepa arm … and confirm the R-It results for prior event population in 2023

Will AMRN prevail in their infringement case

Will EU / UK coverage be mainly for secondary prevention / prior event patients
Etc etc

All of the above should play out by end of 2023

Kiwi

[ggwpq]

"clean up the balance sheet"? There is nothing to clean up regarding Amarin's BS.